Efficacy and Safety
34
8
9
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 34 trials
100.0%
+13.5% vs benchmark
21%
7 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (34)
Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism
A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment
Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients
A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis
Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
Safety and Efficacy of IMPT or IMRT for Breast Cancer
A Phase 2 Clinical Study of CU-20401
MSC Intratissular Injection in Crohn Disease Patients
Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Thermal Ablation Versus Parathyroidectomy for Secondary Hyperparathyroidism
Thermal Ablation Versus Parathyroidectomy for Primary Hyperparathyroidism
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma